Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
0.0%
1w
4.9%
1m
18.2%
3m
22.3%
6m
0.2%
1y
51.5%
5y
40.0%
all
30.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 5.67 0%
5.67
8.42
Company Overview

Sales
6.49 Cr
Growth: -34.5%
Profit after Tax
-16.6 Cr
Growth: -51.4%
Micro Cap
28.4 Cr
P/S: 4.4x
Industry P/S: 2.9x
Fundamentals

Sales (Cr) ₹ 6.49
Growth -34.5%
EBITDA N/A
P/S 4.4x
Dividend 0.0%
P/E -1.7x
Book Value ₹ 7.39
PEG Ratio 0.0x
ROE -39.0%
P/B 0.8x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (19)
Followers (3)